Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,270,227
+$1,771,578 QoQ
Shares Held
174,785
+16.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#90
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. RLAY ranks #28 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
65,798 | $32,683,840 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
38,534 | $24,027,490 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
55,332 | $16,656,591 | |
| 4 | MRNA |
Moderna, Inc.
|
111,906 | $7,836,777 | |
| 5 | INCY |
Incyte Corp
|
44,663 | $5,062,997 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
33,369 | $4,429,067 | |
| 7 | ORKA |
Oruka Therapeutics, Inc.
|
43,110 | $4,102,778 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
35,287 | $4,046,360 |
All Filings in RLAY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,270,227 | 174,785 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,498,649 | 150,618 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,639,175 | 193,756 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $791,221 | 151,575 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $629,571 | 181,957 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $537,278 | 205,068 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,028,191 | 249,561 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,274,612 | 180,030 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,264,436 | 193,932 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,851,698 | 464,060 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,606,303 | 327,548 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,176,835 | 377,745 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,875,283 | 627,013 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $7,306,520 | 443,626 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $7,085,728 | 474,279 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,387,182 | 196,119 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,050,141 | 182,098 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,096,300 | 170,274 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,834,961 | 190,002 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,061,436 | 97,096 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,789,072 | 76,225 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,931,847 | 84,809 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $455,871 | 10,969 | Shares | Sole | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||